Karyopharm therapeutics EVP Cheng sells $2089 in stock
NegativeFinancial Markets

Karyopharm Therapeutics' Executive Vice President, Cheng, has sold $2,089 worth of stock, raising concerns among investors about potential insider trading or lack of confidence in the company's future. Such sales can often signal that executives may not believe the stock will perform well, which can negatively impact investor sentiment and stock prices.
— Curated by the World Pulse Now AI Editorial System